Cardinal Health Receives Multiple Bids for Unit from Curium Pharma and HIG Capital
April 28, 2023
Trending News 🌥️
Cardinal Health ($NYSE:CAH), a healthcare services and products company, has reportedly received multiple bids from France’s Curium Pharma and HIG Capital for one of its units. The unit in question is said to provide diagnostic imaging services. According to sources, the bids are expected to be finalized in the coming weeks. Cardinal Health is a publicly traded company whose operations span the entire healthcare continuum, from hospitals and pharmacies to long-term care facilities and home-based care. The company’s products and services include drugs, medical supplies, and health technologies, as well as other healthcare-related services. In recent years, Cardinal Health has invested heavily in the areas of advanced analytics, telehealth, digital health, personalized medicine, and pharmacy automation. This has allowed it to become one of the largest healthcare companies in the world. As the leading provider of diagnostic imaging services in the United States, the acquisition would strengthen Cardinal Health’s position in the market.
Additionally, with its strong presence across Europe and the United States, the acquisition would also help it extend its reach into more global markets. It remains to be seen if a deal will be finalized in the coming weeks, but it is clear that Cardinal Health is making a strong effort to increase its offerings and grow its market share.
Price History
On Wednesday, Cardinal Health saw its stock open at $80.4 and close at the same price, representing a dip of 0.6% from the previous closing price of $80.9. While it is unknown as to which unit these companies are attempting to acquire, the multiple bids indicate that Cardinal Health is likely to receive an attractive offer for their assets. It remains to be seen how Cardinal Health will respond to these offers, but it appears that the future of the company is bright. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Cardinal Health. More…
| Total Revenues | Net Income | Net Margin |
| 193.01k | -1.27k | -0.2% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Cardinal Health. More…
| Operations | Investing | Financing |
| 3.19k | -405 | -2.28k |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Cardinal Health. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 44.48k | 46.69k | -6.8 |
Key Ratios Snapshot
Some of the financial key ratios for Cardinal Health are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 8.8% | -3.0% | -0.0% |
| FCF Margin | ROE | ROA |
| 1.4% | 2.2% | -0.1% |
Analysis
At GoodWhale, we’ve conducted an analysis of CARDINAL HEALTH‘s wellbeing to provide investors with a better understanding of what they’re investing in. After careful evaluation, we’ve determined that the company is a medium risk investment based on our Risk Rating. We’ve also identified 1 risk warnings in CARDINAL HEALTH’s income sheet. To learn more about these risks, register on goodwhale.com and check out our in-depth analysis. We’re confident that our data-driven insights will help you make better investment decisions. More…
Peers
Its competitors are AmerisourceBergen Corp, McKesson Corp, and Sigma Healthcare Ltd.
– AmerisourceBergen Corp ($NYSE:ABC)
AmerisourceBergen Corp is a drug wholesaler that was founded in 1985. The company has a market cap of 32.4B as of 2022 and a return on equity of 417.0%. AmerisourceBergen Corp distributes prescription drugs and other healthcare products and services to healthcare providers and pharmaceutical companies. The company operates in two segments, Pharmaceutical Distribution and Other.
– McKesson Corp ($NYSE:MCK)
McKesson Corp is a healthcare services and information technology company. It has a market cap of 55.96B as of 2022 and a Return on Equity of -74.43%. The company provides a range of services and products to healthcare providers, payers, and consumers. These services and products include prescription drugs, medical supplies, and software and technology solutions.
– Sigma Healthcare Ltd ($ASX:SIG)
Sigma Healthcare Ltd is a pharmaceutical company with a market cap of 683.23M as of 2022 and a ROE of 0.46%. The company manufactures and distributes a range of prescription and over-the-counter medicines, medical devices, and other healthcare products.
Summary
Cardinal Health has received numerous bids from potential buyers, including France’s Curium Pharma and HIG Capital. This comes as the company has been looking to divest its Pharmaceutical segment. Many investors are viewing the divestment as an opportunity to capitalize on Cardinal Health’s strong position in the healthcare sector.
The company has a long history of providing quality medical products and services, and many investors are optimistic about the potential for financial returns once the divestiture is complete. With a focus on driving growth and long-term value, investors are confident that Cardinal Health will be able to leverage its strengths and position itself for success in the future.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
